Background: Gestational diabetes mellitus (GDM) is a common metabolic disorder characterized by glucose intolerance and associated with adverse maternal and fetal outcomes. Emerging evidence suggests that oxidative stress and hypoxia-related pathways may contribute to its pathophysiology. This study aimed to evaluate the diagnostic performance of serum sestrin-2 (SESN-2) and hypoxia-inducible factor-1alpha (HIF-1α) as potential biomarkers in GDM. Methods: In this case–control study, 100 pregnant women (50 with GDM and 50 controls) were enrolled. Serum SESN-2 and HIF-1α levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: Patients with GDM showed significantly higher body mass index, glucose levels, glycated hemoglobin (HbA1c), insulin, and C-reactive protein (CRP) (all p < 0.05). SESN-2 and HIF-1α levels were significantly elevated (both p < 0.0001). Receiver operating characteristic (ROC) analysis showed area-under-the-curve (AUC) values of 0.799 for SESN-2 and 0.769 for HIF-1α, which increased to 0.909 when combined. Both biomarkers were independently associated with GDM in multivariable analysis. Conclusions: SESN-2 and HIF-1α levels are elevated in GDM and are associated with its presence. These biomarkers demonstrated moderate diagnostic performance, and their combined use improved discrimination; however, they should be considered complementary rather than standalone diagnostic tools. Given the cross-sectional design, the findings reflect associations rather than predictive relationships, and further prospective studies are required to clarify their clinical utility.
Dönmez et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: